Chouaid C, Bosquet L, Knott C, Li Z, et al. Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study. Lung Cancer 2025;203:108548.
PMID: 40262227